Exploring Factors That Prolong the Diagnosis of Myasthenia Gravis-Reference-Cited by-同舟云学术

Exploring Factors That Prolong the Diagnosis of Myasthenia Gravis

Published:2024-02 Issue:1 Volume:14 Page:
ISSN:2163-0402
Container-title:Neurology Clinical Practice
language:en
Short-container-title:Neur Clin Pract

Author:

Nguyen Minh¹^ORCID,Clough Meaghan¹^ORCID,Cruse Belinda¹^ORCID,van der Walt Anneke¹^ORCID,Fielding Joanne¹^ORCID,White Owen B.¹^ORCID

Affiliation:

1. Department of Neuroscience (MN, MC, AW, JF, OBW), Monash Health; Department of Neurology (BC), Royal Melbourne Hospital; and Department of Neurology (MN, AW), Alfred Health, Melbourne, Australia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/CPJ.0000000000200244

Reference32 articles.

1. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis

2. Myasthenia Gravis (MG): Epidemiological Data and Prognostic Factors

3. Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles

4. Factors associated with quality of life of people with Myasthenia Gravis

5. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No sex‐based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study;Muscle & Nerve;2024-07-26

2. Recommendations for the management of myasthenia gravis in Belgium;Acta Neurologica Belgica;2024-04-22